Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT01779050
Title Effect of Trastuzumab on Disease Free Survival in Early Stage HER2-Negative Breast Cancer Patients With ERBB2 Expressing Disseminated Tumor Cells
Recruitment Terminated
Gender female
Phase Phase II
Variant Requirements No
Sponsors Washington University School of Medicine
Indications
Therapies
Age Groups: adult
Covered Countries USA


No variant requirements are available.